4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0000899243-20-027695
Director acquired 489,542 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DOWNEY BRUCE Director | 2020-10-06 | Conversion | +237,148 | 237,148 | D | ||
| DOWNEY BRUCE Director | 2020-10-06 | Conversion | +252,394 | 489,542 | D | ||
| Derivatives | |||||||
| DOWNEY BRUCE Director | 2020-10-06 | Conversion · Series A Preferred Stock | −2,000,000 | 0 | D | ||
| DOWNEY BRUCE Director | 2020-10-06 | Conversion · Series B Preferred Stock | −2,128,571 | 0 | D | ||
Loading xslF345X03/doc4.xml…